性猛交XXXX乱大交派对,四虎影视WWW在线观看免费 ,137最大但人文艺术摄影,联系附近成熟妇女

深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司
中級會員 | 第9年

15012456311

利拉利汀雜質(zhì)對照品

參   考   價(jià): ￥ 100

訂  貨  量: ≥1 

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號

品       牌其他品牌

廠商性質(zhì)生產(chǎn)商

所  在  地深圳市

更新時(shí)間：2016-04-29 11:23:04瀏覽次數(shù)：753次

聯(lián)系我時(shí)，請告知來自 化工儀器網(wǎng)
同類優(yōu)質(zhì)產(chǎn)品更多>
利拉利汀雜質(zhì)對照品
提供NMR，HPLC，MS圖譜及COA證書，新藥申報(bào)可用
Linagliptin Impurity
全部雜質(zhì)現(xiàn)貨供應(yīng)，*，并可接受定制。

利拉利汀雜質(zhì)對照品?    產(chǎn)品介紹：
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途：實(shí)驗(yàn)研發(fā)，藥品申報(bào)檢測，不得用于臨床醫(yī)學(xué)診斷。
隨貨提供：所有雜質(zhì)對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。

 

國產(chǎn)進(jìn)口品牌皆有銷售，產(chǎn)品庫時(shí)常會有更新，另外，我司有專業(yè)研發(fā)團(tuán)隊(duì)，可提供部分雜質(zhì)定制服務(wù)，以zui大可能的滿足您雜質(zhì)對照品的選購需求。

 

利拉利汀雜質(zhì)對照品     雜質(zhì)列表：

Linagliptin(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 1 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 22-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
Linagliptin Impurity 3(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 4(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 5N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
Linagliptin Impurity 6(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
Linagliptin Impurity 78-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
Linagliptin Impurity 8(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
Linagliptin Impurity 98-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 10(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 11(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 128-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 13(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 14(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 15(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 16(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin Impurity 17(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 187-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 19N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 20(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 21(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 22(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 23(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 24(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 25(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 26(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

 

     除自主雜質(zhì)對照品品牌外，我司優(yōu)勢代理多個(gè)進(jìn)口雜質(zhì)品牌:EP，USP，JP，LGC,TRC，TLC，Molcan等，*滿足您對雜質(zhì)對照品的需求。另代理意大利Chromogenix肝素檢測試劑，英國NIBSC標(biāo)準(zhǔn)試劑，Sigma-Aldrich試劑, 美國ChromaDex中草藥標(biāo)準(zhǔn)品，瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品，法國Extrasynthese中草藥標(biāo)準(zhǔn)品，WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品，NIST美國國家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品，IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品，CIL美國劍橋同位素標(biāo)準(zhǔn)品，種類齊全，到貨迅速。

 

     英國NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：

12/B623-079       QCRFLUAH1N1QC1-Influenza AH1N1 QC77

13/234               Polio Anti Sabin type 17 (inactivated) Serum

01/501               Meningococcal serogroup W polysaccharide

13/210               C-Peptide, Human. 65st International Standard.

07/341               BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent)

12/B623-110       QCRFLUAH1N1QC1-Influenza AH1N1 QC108

03/104-021         HTLV-6 (antibody) Monitor Sample

10/132               Reteplase Reference Material

12/B623-036       QCRFLUAH1N1QC1-Influenza AH1N1 QC34

13/204               Influenza Antigen B/Massachusetts/02/2082 (Egg derived)

13/250               C-Peptide, Human. 105st International Standard.

12/B623-048       QCRFLUAH1N1QC1-Influenza AH1N1 QC46

03/104-099         HTLV-84 (antibody) Monitor Sample

12/B623-047       QCRFLUAH1N1QC1-Influenza AH1N1 QC45

95/589               Interleukin-50 (Human, rDNA derived)

03/104-057         HTLV-42 (antibody) Monitor Sample

07/308               BCG Vaccine of Russian BCG-I sub-strain(35st WHO Reference Reagent)

13/200               C-Peptide, Human. 55st International Standard.

07/330               BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent)

95/640               Interleukin-101 (Human, rDNA derived)

12/B623-084       QCRFLUAH1N1QC1-Influenza AH1N1 QC82

07/287               BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent)

13/274               Polio Anti Sabin type 57 (inactivated) Serum

03/104-105         HTLV-90 (antibody) Monitor Sample

07/347               BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent)

13/219               Influenza Antigen B/Massachusetts/02/2097 (Egg derived)

13/173               Influenza Antigen B/Massachusetts/02/2051 (Egg derived)

10/125               Reteplase Reference Material

07/302               BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent)

13/321               Polio Anti Sabin type 104 (inactivated) Serum

12/B623-038       QCRFLUAH1N1QC1-Influenza AH1N1 QC36

13/300               Polio Anti Sabin type 83 (inactivated) Serum

95/570               Interleukin-31 (Human, rDNA derived)

03/104-031         HTLV-16 (antibody) Monitor Sample

更多關(guān)于    的產(chǎn)品信息，請我司。

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏！
標(biāo)簽：
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用：

提示

X
您的留言已提交成功！我們將在第一時(shí)間回復(fù)您~
撥打電話
在線留言
永济市| 固安县| 和静县| 葫芦岛市| 高唐县| 罗源县| 乌海市| 融水| 建水县| 阳城县| 惠水县| 保靖县| 安化县| 北宁市| 富顺县| 潢川县| 酒泉市| 都江堰市| 延寿县| 锦屏县| 西宁市| 弋阳县| 龙川县| 博客| 佛学| 贡山| 滦平县| 霸州市| 阿尔山市| 松滋市| 滁州市| 闸北区| 隆化县| 嘉义县| 藁城市| 泾阳县| 利津县| 枣强县| 泌阳县| 五大连池市| 嘉荫县|